Showing results (21-30 of 823) with videos related to

Sort By:
Pageof 83
Leukemia|August 30, 2019
Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myelomaArghya Ray, Yan Song, Ting Du, et al.
Hematology/Oncology Clinics of North America|September 13, 2014
Novel targeted agents in the treatment of multiple myelomaCindy Varga, Jacob Laubach, Teru Hideshima, et al.
Oncology (Williston Park, N.Y.)|April 2, 2014
The heavy chain diseases: clinical and pathologic featuresGiada Bianchi, Kenneth C Anderson, Nancy Lee Harris, et al.
Blood|April 26, 2003
Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytesToshiaki Hayashi, Teru Hideshima, Masaharu Akiyama, et al.
Blood|October 24, 2002
Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieuTeru Hideshima, Masaharu Akiyama, Toshiaki Hayashi, et al.
Cancer Research|October 16, 2003
Blockade of Hsp27 overcomes Bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cellsDharminder Chauhan, Guilan Li, Reshma Shringarpure, et al.
Cancer Metastasis Reviews|December 3, 2017
The proteasome and proteasome inhibitors in multiple myelomaSara Gandolfi, Jacob P Laubach, Teru Hideshima, et al.
Biochemical and Biophysical Research Communications|December 3, 2002
The extracellular calcium Ca2+o-sensing receptor is expressed in myeloma cells and modulates cell proliferationToru Yamaguchi, Mika Yamauchi, Toshitsugu Sugimoto, et al.
British Journal of Haematology|October 13, 2015
Synergistic anti-myeloma activity of the proteasome inhibitor marizomib and the IMiD immunomodulatory drug pomalidomideDeepika S Das, Arghya Ray, Yan Song, et al.
British Journal of Haematology|September 29, 2011
Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cellsDharminder Chauhan, Madhavi Bandi, Ajita V Singh, et al.
Pageof 83